The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. The inability of chemotherapeutic drugs to selectively target HCC tumor cells because of their predominant resistant phenotype to most conventional anticancer agents bestows a major obstacle for the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Hongping, Chen, Jianxiang, Shi, Ming, Deivasigamani, Amudha, P.J. Ooi, London Lucien, Hui, Kam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467416/
https://www.ncbi.nlm.nih.gov/pubmed/25714025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467416/
https://www.ncbi.nlm.nih.gov/pubmed/25714025

Ejemplares similares